rs45575136

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000214.3(JAG1):​c.924C>T​(p.Asn308=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0287 in 1,613,892 control chromosomes in the GnomAD database, including 933 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 84 hom., cov: 32)
Exomes 𝑓: 0.029 ( 849 hom. )

Consequence

JAG1
NM_000214.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.0580
Variant links:
Genes affected
JAG1 (HGNC:6188): (jagged canonical Notch ligand 1) The jagged 1 protein encoded by JAG1 is the human homolog of the Drosophilia jagged protein. Human jagged 1 is the ligand for the receptor notch 1, the latter is involved in signaling processes. Mutations that alter the jagged 1 protein cause Alagille syndrome. Jagged 1 signalling through notch 1 has also been shown to play a role in hematopoiesis. [provided by RefSeq, Nov 2019]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 20-10652213-G-A is Benign according to our data. Variant chr20-10652213-G-A is described in ClinVar as [Benign]. Clinvar id is 42483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-10652213-G-A is described in Lovd as [Benign]. Variant chr20-10652213-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.058 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0658 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
JAG1NM_000214.3 linkuse as main transcriptc.924C>T p.Asn308= synonymous_variant 7/26 ENST00000254958.10 NP_000205.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
JAG1ENST00000254958.10 linkuse as main transcriptc.924C>T p.Asn308= synonymous_variant 7/261 NM_000214.3 ENSP00000254958 P1P78504-1
JAG1ENST00000423891.6 linkuse as main transcriptn.790C>T non_coding_transcript_exon_variant 5/252
JAG1ENST00000617965.2 linkuse as main transcriptn.293C>T non_coding_transcript_exon_variant 2/175

Frequencies

GnomAD3 genomes
AF:
0.0246
AC:
3743
AN:
152106
Hom.:
84
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00655
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0689
Gnomad ASJ
AF:
0.00288
Gnomad EAS
AF:
0.0135
Gnomad SAS
AF:
0.0418
Gnomad FIN
AF:
0.0328
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0255
Gnomad OTH
AF:
0.0273
GnomAD3 exomes
AF:
0.0371
AC:
9328
AN:
251388
Hom.:
287
AF XY:
0.0348
AC XY:
4723
AN XY:
135864
show subpopulations
Gnomad AFR exome
AF:
0.00652
Gnomad AMR exome
AF:
0.108
Gnomad ASJ exome
AF:
0.00199
Gnomad EAS exome
AF:
0.0113
Gnomad SAS exome
AF:
0.0435
Gnomad FIN exome
AF:
0.0349
Gnomad NFE exome
AF:
0.0261
Gnomad OTH exome
AF:
0.0298
GnomAD4 exome
AF:
0.0291
AC:
42533
AN:
1461668
Hom.:
849
Cov.:
32
AF XY:
0.0290
AC XY:
21072
AN XY:
727142
show subpopulations
Gnomad4 AFR exome
AF:
0.00505
Gnomad4 AMR exome
AF:
0.104
Gnomad4 ASJ exome
AF:
0.00226
Gnomad4 EAS exome
AF:
0.0169
Gnomad4 SAS exome
AF:
0.0422
Gnomad4 FIN exome
AF:
0.0333
Gnomad4 NFE exome
AF:
0.0270
Gnomad4 OTH exome
AF:
0.0250
GnomAD4 genome
AF:
0.0246
AC:
3747
AN:
152224
Hom.:
84
Cov.:
32
AF XY:
0.0259
AC XY:
1930
AN XY:
74448
show subpopulations
Gnomad4 AFR
AF:
0.00653
Gnomad4 AMR
AF:
0.0693
Gnomad4 ASJ
AF:
0.00288
Gnomad4 EAS
AF:
0.0137
Gnomad4 SAS
AF:
0.0412
Gnomad4 FIN
AF:
0.0328
Gnomad4 NFE
AF:
0.0254
Gnomad4 OTH
AF:
0.0270
Alfa
AF:
0.0229
Hom.:
20
Bravo
AF:
0.0265
Asia WGS
AF:
0.0300
AC:
104
AN:
3478
EpiCase
AF:
0.0232
EpiControl
AF:
0.0243

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineFeb 10, 2016p.Asn308Asn in exon 7 of JAG1:This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue and is not located with in the splice consensus sequence. It has been identified in 11% (1274/11536) of Latino chromosomes, including 73 homozygotes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs45575136). -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpApr 09, 2023- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
not provided Benign:2
Likely benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Isolated Nonsyndromic Congenital Heart Disease Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Alagille syndrome due to a JAG1 point mutation Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJun 12, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.57
CADD
Benign
3.1
DANN
Benign
0.88
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs45575136; hg19: chr20-10632861; API